Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, 08 1995, 1881-1884, Vol 39, No. 8
F Danel, LM Hall, D Gur and DM Livermore
Pseudomonas aeruginosa 455, isolated in Ankara, Turkey, produced a pI 6.2
beta-lactamase determined by plasmid pMLH53 and resisted all beta- lactams
except carbapenems. This beta-lactamase, named OXA-14, corresponded to
OXA-10 (PSE-2) except that aspartate replaced glycine at position 157 and
thus is intermediate between OXA-10 and OXA-11, which has aspartate at
position 157 and a further substitution at position 143.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
OXA-14, another extended-spectrum variant of OXA-10 (PSE-2) beta- lactamase from Pseudomonas aeruginosa
Department of Medical Microbiology, London Hospital Medical College, United Kingdom.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»